Cue Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $99.5M
Liabilities Breakdown FY2020
Total Liabilities: $20.6M
Asset Breakdown
Total Assets: $99.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $74.9M | 75.2% |
| Accounts Receivable | $1.4M | 1.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.1M | 2.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $21.1M | 21.2% |
Liabilities Breakdown
Total Liabilities: $20.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 10.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $18.6M | 90.0% |